TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: waist/hip ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fasting & 2-h post prandial blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in tumour cellular redox status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in uptake of [18F]F-AraG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent pathologic response at the time of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: release of pro-inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Survivors
Endpoint domain: Mortality/survival
Primary endpoint: Confirmed or suspected cases of Multisystem inflammatory syndrome in children
Endpoint domain: Adverse events/effects
Primary endpoint: Caregiver and Youth General Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Youth Emotional Problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of patients with active locking of the operated knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of Primary Emergence of Mucosal p16-Positive Squamous Cell Carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Major pathological response (MPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hair growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in functional and neurological status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Preoperative Asprosin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived sensation score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of subjects with quantifiable detection of molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication adherence (objective measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication adherence (subjective measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in basal tear secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure of High Flow Nasal Cannula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Failure of Non Invasive Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Endurance capacity of anterior deep trunk muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance capacity of lateral core muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance test by Prokin system for perimeter parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal bone loss around dental implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Falls efficacy scale (Tinetti)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Timed Get Up and Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Zero to Infinity (AUC[0-∞]) of Selpercatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Time Zero to the Last Measured Concentration Value (AUC[0-tlast]) of Selpercatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Selpercatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Heart Rate during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: frequency of serious adverse reactions (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of unexpected adverse reactions (SUSARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of left atrial appendage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bioavailability of [F]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root Mean Squared Error (RMSE) of Respiration Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fall efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of atrial high rate episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Active choice
Endpoint domain: Life impact
Endpoint subdomain: Decision-making
Primary endpoint: Intention strength
Endpoint domain: Life impact
Endpoint subdomain: Behavioral intention
Primary endpoint: Commitment
Endpoint domain: Life impact
Endpoint subdomain: Behavioral commitment
Primary endpoint: Number of Participants With All Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Area Under the Curve (AUC) of SARS-CoV-2 Viral Load From Day 1 to Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Lymphoedema-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mechanical stress via the MyotonPro
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Stiffness via the MyotonPro
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Cycle time via the Biodex Gait Trainer 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total radioactivity recovered in whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration (AUC[0-T])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and proportion of bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: UTI-free duration in 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: UTI recurrent incidence in 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cognard's classification grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who completed listening sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who completed clinician/administrator pre-trial interviews
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Excretion of total radioactivity in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excretion of total radioactivity in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intraday FEV1 declines of ≥10%, ≥15%, and ≥20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Occurrence of PEFR decline of ≥ 30% from the established baseline PEFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Generalized Anxiety Disorder Scale (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Estimation of Pulmonary artery pressure (PAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right ventricular (RV) function in ml/kg/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular (LV) function in ml/kg/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tinetti Balance And Gait Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Up And Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doppler indices for internal thoracic artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: assessment of fetal thymus size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety of metformin
Endpoint domain: Adverse events/effects
Primary endpoint: Risk for developing pre-diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of PAS index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with advance directive documentation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of potentially burdensome procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Delayed Type Hypersensitivity Skin Reactivity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proliferative T-cell Responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Summary of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Upper Extremity skills test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory perception: tactile sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Force Production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory perception: pressure sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CT-FFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % maximum stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mRS at 90-days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological Well-Being Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incontinence Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time course change in serum glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time course change in serum insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time course change in serum triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time course change in plasma HISS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of biological markers of immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Brunnstrom Recovery Stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Fugl-Meyer Upper Extremity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn blood gases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Program feasibility based on number referred
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in program attendance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Program acceptability based on qualitative components from participant interviews
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to reach decannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of grade 3-5 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of myofascial pelvic pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient perception of treatment delivery by an LVN in comparison to specialist MD
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Patient satisfaction with treatment delivery by an LVN in comparison to specialist MD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Histological differences in glioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Molecular differences in glioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Undetectable Adenovirus Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: QTc interval and cardiac repolarization measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: breathing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Failure of HVNI / NIPPV within 72 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Grade≥3 Treatment-Emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: toxicities of LMB-100
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral NAD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CSF NAD and related metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Expression of the Nicotinamide Riboside Related Pattern (NRRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of MRS responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arithmetic Mean SPF Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of Ultra Fast-track
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of treatment-attributable Grade ≥ 3 adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of acute radiotherapy related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of glial lymphatic system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Psychomotor vigilance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Baropodometer assessments-Pressure distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of regional airway closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: prevalence of complete airway closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference of global AOP values between EIT-derived method and the highest regional AOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment of patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance of treatment sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Traditional, complementary and alternative medicine (TCAM) use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intentional non-adherence to official medical recommendations (iNAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Stigmatizing attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eating Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of Food Cravings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Healthy Life Awareness
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health Perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from preoperative anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Comparison of body temperature measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal pelvis mucosal injury rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Motor evoked potentials (MEPs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Maximum Voluntary Contractions (MVCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fitzpatrick wrinkle scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Wrinkle Severity Rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of postoperative complication
Endpoint domain: Adverse events/effects
Primary endpoint: Skill of Toothbrushing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Return to previous job
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction of staphylococcus aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Absolute change in coronary cross-sectional area (in mm²) within the vericiguat group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative change in coronary cross-sectional area (as percentage) within the vericiguat group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absolute change in coronary cross-sectional area (in mm²) between the vericiguat group and the placebo group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative change in coronary cross-sectional area (as percentage) between the vericiguat group and the placebo group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endoscopic evidence of returned polyposis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of EUS-gastroenterostomy
Endpoint domain: Adverse events/effects
Primary endpoint: Pathogenesis of central nervous system vasculitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Physical health as measured by the EORTC QLQ-C30 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Response rate at week 12 after last treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to sputum culture negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Heart failure rehospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of carious lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient and parental perceived acceptability and comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depth of carious lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of vascular disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Detection of neurological disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Poor outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peripheral transcutaneous oxygen pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of serious or severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Hours of MotionSense Use Per Day in Office
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Days Use After / Prior to Surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient Onboarding Time in Surgeon Clinic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of tax filing at 3 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of tax filing at 9 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area under the curve during steady state (AUCtau, ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal plasma concentration during steady state (Cmaxss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of SIBO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Flexion Range of Motion of the Knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Physical activity intervention feasibility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diet quality intervention feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status